166 related articles for article (PubMed ID: 34007408)
1. Human Tissue Kallikrein 1 Is Downregulated in Elderly Human Prostates and Possesses Potential In Vitro Antioxidative and Antifibrotic Effects in Rodent Prostates.
Zhang M; Luo C; Lin D; Cui K; Chen Z; Liu J
Oxid Med Cell Longev; 2021; 2021():8877540. PubMed ID: 34007408
[TBL] [Abstract][Full Text] [Related]
2. Tissue Kallikrein Protects Rat Prostate against the Inflammatory Damage in a Chronic Autoimmune Prostatitis Model via Restoring Endothelial Function in a Bradykinin Receptor B2-Dependent Way.
Zhang M; Lin D; Luo C; Wei P; Cui K; Chen Z
Oxid Med Cell Longev; 2022; 2022():1247806. PubMed ID: 35154561
[TBL] [Abstract][Full Text] [Related]
3. Preserved Erectile Function in the Aged Transgenic Rat Harboring Human Tissue Kallikrein 1.
Luan Y; Ruan Y; Wang T; Zhuan L; Wen Z; Chen R; Zhang Y; Cui K; Yang J; Wang S; Liu J; Ye Z; Wang D
J Sex Med; 2016 Sep; 13(9):1311-1322. PubMed ID: 27555503
[TBL] [Abstract][Full Text] [Related]
4. Involvement of DDAH/ADMA/NOS/cGMP and COX-2/PTGIS/cAMP Pathways in Human Tissue Kallikrein 1 Protecting Erectile Function in Aged Rats.
Cui K; Luan Y; Tang Z; Rao K; Wang T; Chen Z; Wang S; Liu J; Wang D
PLoS One; 2017; 12(1):e0170427. PubMed ID: 28103290
[TBL] [Abstract][Full Text] [Related]
5. Reduced corporal fibrosis to protect erectile function by inhibiting the Rho-kinase/LIM-kinase/cofilin pathway in the aged transgenic rat harboring human tissue kallikrein 1.
Cui K; Luan Y; Wang T; Zhuan L; Rao K; Wang SG; Ye ZQ; Liu JH; Wang DW
Asian J Androl; 2017; 19(1):67-72. PubMed ID: 27678468
[TBL] [Abstract][Full Text] [Related]
6. Human tissue kallikrein 1 ameliorates erectile function via modulation of macroautophagy in aged transgenic rats.
Tang Z; Cui K; Luan Y; Ruan Y; Wang T; Yang J; Wang S; Liu J; Wang D
Andrology; 2018 Sep; 6(5):766-774. PubMed ID: 29939496
[TBL] [Abstract][Full Text] [Related]
7. Human Tissue Kallikrein 1 Improves Erectile Dysfunction of Streptozotocin-Induced Diabetic Rats by Inhibition of Excessive Oxidative Stress and Activation of the PI3K/AKT/eNOS Pathway.
Luan Y; Cui K; Tang Z; Ruan Y; Liu K; Wang T; Chen Z; Wang S; Liu J
Oxid Med Cell Longev; 2020; 2020():6834236. PubMed ID: 32190176
[TBL] [Abstract][Full Text] [Related]
8. Significance of the tissue kallikrein promoter and transforming growth factor-beta1 polymorphisms with renal progression in children with vesicoureteral reflux.
Lee-Chen GJ; Liu KP; Lai YC; Juang HS; Huang SY; Lin CY
Kidney Int; 2004 Apr; 65(4):1467-72. PubMed ID: 15086490
[TBL] [Abstract][Full Text] [Related]
9. Profiling molecular targets of TGF-beta1 in prostate fibroblast-to-myofibroblast transdifferentiation.
Untergasser G; Gander R; Lilg C; Lepperdinger G; Plas E; Berger P
Mech Ageing Dev; 2005 Jan; 126(1):59-69. PubMed ID: 15610763
[TBL] [Abstract][Full Text] [Related]
10. Kallikrein gene expression in human pituitary tissues.
Clements JA; Mukhtar A; Verity K; Pullar M; McNeill P; Cummins J; Fuller PJ
Clin Endocrinol (Oxf); 1996 Feb; 44(2):223-31. PubMed ID: 8849579
[TBL] [Abstract][Full Text] [Related]
11. Human tissue kallikrein-1 protects against the development of erectile dysfunction in a rat model of hyperhomocysteinemia.
Cui K; Luan Y; Tang Z; Li CC; Wang T; Wang SG; Chen Z; Liu JH
Asian J Androl; 2019; 21(5):508-515. PubMed ID: 30618416
[TBL] [Abstract][Full Text] [Related]
12. Tissue kallikrein and the bradykinin B2 receptor are expressed in endometrial and prostate cancers.
Clements J; Mukhtar A
Immunopharmacology; 1997 Jun; 36(2-3):217-20. PubMed ID: 9228549
[TBL] [Abstract][Full Text] [Related]
13. Tissue kallikrein mediates pro-inflammatory pathways and activation of protease-activated receptor-4 in proximal tubular epithelial cells.
Yiu WH; Wong DW; Chan LY; Leung JC; Chan KW; Lan HY; Lai KN; Tang SC
PLoS One; 2014; 9(2):e88894. PubMed ID: 24586431
[TBL] [Abstract][Full Text] [Related]
14. Tissue kallikrein attenuates salt-induced renal fibrosis by inhibition of oxidative stress.
Zhang JJ; Bledsoe G; Kato K; Chao L; Chao J
Kidney Int; 2004 Aug; 66(2):722-32. PubMed ID: 15253727
[TBL] [Abstract][Full Text] [Related]
15. Tissue kallikrein KLK1 is expressed de novo in endothelial cells and mediates relaxation of human umbilical veins.
Dedio J; Wiemer G; Rütten H; Dendorfer A; Schölkens BA; Müller-Esterl W; Wohlfart P
Biol Chem; 2001 Oct; 382(10):1483-90. PubMed ID: 11727832
[TBL] [Abstract][Full Text] [Related]
16. Kallikrein gene transfer reduces renal fibrosis, hypertrophy, and proliferation in DOCA-salt hypertensive rats.
Xia CF; Bledsoe G; Chao L; Chao J
Am J Physiol Renal Physiol; 2005 Sep; 289(3):F622-31. PubMed ID: 15886273
[TBL] [Abstract][Full Text] [Related]
17. Kallistatin ameliorates influenza virus pathogenesis by inhibition of kallikrein-related peptidase 1-mediated cleavage of viral hemagglutinin.
Leu CH; Yang ML; Chung NH; Huang YJ; Su YC; Chen YC; Lin CC; Shieh GS; Chang MY; Wang SW; Chang Y; Chao J; Chao L; Wu CL; Shiau AL
Antimicrob Agents Chemother; 2015 Sep; 59(9):5619-30. PubMed ID: 26149981
[TBL] [Abstract][Full Text] [Related]
18. S(1)' and S(2)' subsite specificities of human plasma kallikrein and tissue kallikrein 1 for the hydrolysis of peptides derived from the bradykinin domain of human kininogen.
Lima AR; Alves FM; Angelo PF; Andrade D; Blaber SI; Blaber M; Juliano L; Juliano MA
Biol Chem; 2008 Dec; 389(12):1487-94. PubMed ID: 18844446
[TBL] [Abstract][Full Text] [Related]
19. Genetically‑modified stem cells in treatment of human diseases: Tissue kallikrein (KLK1)‑based targeted therapy (Review).
Devetzi M; Goulielmaki M; Khoury N; Spandidos DA; Sotiropoulou G; Christodoulou I; Zoumpourlis V
Int J Mol Med; 2018 Mar; 41(3):1177-1186. PubMed ID: 29328364
[TBL] [Abstract][Full Text] [Related]
20. Specific inhibition of tissue kallikrein 1 with a human monoclonal antibody reveals a potential role in airway diseases.
Sexton DJ; Chen T; Martik D; Kuzmic P; Kuang G; Chen J; Nixon AE; Zuraw BL; Forteza RM; Abraham WM; Wood CR
Biochem J; 2009 Aug; 422(2):383-92. PubMed ID: 19527222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
